Illumina wraps lab automation and software around HiSeq X to lower barrier to mass sequencing

Illumina's HiSeq X Ten is designed to sequence a human genome for $1,000.
Illumina's HiSeq X Ten genome sequencing system

Illumina ($ILMN) has introduced a suite of tools and software to help research organizations new to population-scale sequencing to get started with its HiSeq X Ten and Five systems. The move comes one month after BGI joined the large-scale sequencing field with a package that covers each step of the process, from sample preparation to data analysis.

San Diego, CA-based Illumina has good reasons to introduce its own package. Long before BGI stepped up competition in the population-scale sequencing field, Illumina was commenting on how surprised it was by the level of interest in HiSeq X Ten from organizations with minimal experience in the field. BGI has pitched its sequencing system, Revolocity, at such operations by trying to make it as close to a plug-and-play platform as is possible. Illumina has always provided end-to-end support, through integration with NeoPrep and Basespace, but the new offering formalizes the package.

By removing some of the technical barriers to setting up a population-scale sequencing system, Illumina will position itself to target a bigger pool of possible customers. "This complete solution was important in our decision to purchase the HiSeq X System and to undertake population-scale whole-genome sequencing of large well-characterized cohorts in Scotland," Professor David Hume, director of The Roslin Institute at the University of Edinburgh, said in a statement. The Roslin Institute is part of a project to install 15 HiSeq X sequencers in Scotland.

As well as the sequencers, the Scottish research consortium will gain access to Clarity LIMS X Edition, Microlab STAR liquid handling robotics, HiSeq Analysis Software v2.0 and Illumina SeqLab Consulting Service. Illumina has worked with GenoLogics and Hamilton Robotics--the makers of Clarity LIMS and Microlab Star, respectively--to put together the integrated package. The suite is designed to enable any lab to get their sequencing operation up to full speed in 6 weeks, a timeline that is achieved by removing the burden of developing and configuring automation and software systems.

- read the release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.